Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Weiland

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
Lakartidningen|June 22, 1977
[Myalgia cruris, again current in Stockholm]E Bengtsson, G Lind, O Weiland
Lancet (London, England)|April 26, 1986
Non-A, non-B hepatitis after intravenous gammaglobulinO Weiland, L Mattsson, H Glaumann
Scandinavian Journal of Infectious Diseases|January 1, 1988
Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulinR Schvarcz, O Weiland, H Glaumann
Liver|October 1, 1990
Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis CL Mattsson, O Weiland, H Glaumann
Liver|October 1, 1993
Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markersL Mattsson, A Sönnerborg, O Weiland
Journal of Hepatology|April 1, 1993
Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitisR Schvarcz, H Glaumann, O Weiland
Cancer Letters|June 1, 1979
The EBV-carrying, beta2M/HLA deficient Burkitt lymphoma line Daudi is sensitive to EBV-specific killer T-cells of mononucleosis patientsE Svedmyr, G Klein, O Weiland
Scandinavian Journal of Gastroenterology|March 6, 2004
Histological findings, genotype distribution and percentage of patients fulfilling the treatment criteria among patients with chronic hepatitis C virus infection in a single Swedish centreA Hollander, H Glaumann, O Weiland
Scandinavian Journal of Infectious Diseases|January 1, 1994
Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained responseO Reichard, H Glaumann, O Weiland
Liver|June 1, 1988
Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcomeL Mattsson, O Weiland, H Glaumann
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
Lakartidningen|June 22, 1977
[Myalgia cruris, again current in Stockholm]E Bengtsson, G Lind, O Weiland
Lancet (London, England)|April 26, 1986
Non-A, non-B hepatitis after intravenous gammaglobulinO Weiland, L Mattsson, H Glaumann
Scandinavian Journal of Infectious Diseases|January 1, 1988
Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulinR Schvarcz, O Weiland, H Glaumann
Liver|October 1, 1990
Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis CL Mattsson, O Weiland, H Glaumann
Liver|October 1, 1993
Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markersL Mattsson, A Sönnerborg, O Weiland
Journal of Hepatology|April 1, 1993
Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitisR Schvarcz, H Glaumann, O Weiland
Cancer Letters|June 1, 1979
The EBV-carrying, beta2M/HLA deficient Burkitt lymphoma line Daudi is sensitive to EBV-specific killer T-cells of mononucleosis patientsE Svedmyr, G Klein, O Weiland
Scandinavian Journal of Gastroenterology|March 6, 2004
Histological findings, genotype distribution and percentage of patients fulfilling the treatment criteria among patients with chronic hepatitis C virus infection in a single Swedish centreA Hollander, H Glaumann, O Weiland
Scandinavian Journal of Infectious Diseases|January 1, 1994
Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained responseO Reichard, H Glaumann, O Weiland
Liver|June 1, 1988
Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcomeL Mattsson, O Weiland, H Glaumann
Pageof 17